Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Analysis of safety data in clinical trials using a recurrent event approach.

Gong Q, Tong B, Strasak A, Fang L.

Pharm Stat. 2014 Mar-Apr;13(2):136-44. doi: 10.1002/pst.1611. Epub 2014 Feb 11.

PMID:
24519954
2.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

3.

Semiparametric transformation models for joint analysis of multivariate recurrent and terminal events.

Zhu L, Sun J, Srivastava DK, Tong X, Leisenring W, Zhang H, Robison LL.

Stat Med. 2011 Nov 10;30(25):3010-23. doi: 10.1002/sim.4306. Epub 2011 Jul 22.

PMID:
21786280
4.

Graphical approaches to the analysis of safety data from clinical trials.

Amit O, Heiberger RM, Lane PW.

Pharm Stat. 2008 Jan-Mar;7(1):20-35.

PMID:
17323410
5.

Competing time-to-event endpoints in cardiology trials: a simulation study to illustrate the importance of an adequate statistical analysis.

Rauch G, Kieser M, Ulrich S, Doherty P, Rauch B, Schneider S, Riemer T, Senges J.

Eur J Prev Cardiol. 2014 Jan;21(1):74-80. doi: 10.1177/2047487312460518. Epub 2012 Sep 10.

PMID:
22964966
6.
7.

Analyzing Recurrent Event Data With Informative Censoring.

Wang MC, Qin J, Chiang CT.

J Am Stat Assoc. 2001;96(455). doi: 10.1198/016214501753209031.

8.

Analysis of multivariate recurrent event data with time-dependent covariates and informative censoring.

Zhao X, Liu L, Liu Y, Xu W.

Biom J. 2012 Sep;54(5):585-99. doi: 10.1002/bimj.201100194. Epub 2012 Aug 7.

PMID:
22886587
9.

Summarizing the incidence of adverse events using volcano plots and time intervals.

Zink RC, Wolfinger RD, Mann G.

Clin Trials. 2013;10(3):398-406. doi: 10.1177/1740774513485311.

PMID:
23690094
11.
12.

Considerations in choice of a clinical endpoint for AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA).

Neaton JD, Wentworth DN, Rhame F, Hogan C, Abrams DI, Deyton L.

Stat Med. 1994 Oct 15-30;13(19-20):2107-25. Review.

PMID:
7846414
13.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
14.

Regression analysis of multivariate recurrent event data with a dependent terminal event.

Zhu L, Sun J, Tong X, Srivastava DK.

Lifetime Data Anal. 2010 Oct;16(4):478-90. doi: 10.1007/s10985-010-9158-9. Epub 2010 Mar 10.

PMID:
20217474
15.

Non-parametric inference of adverse events under informative censoring.

Nishikawa M, Tango T, Ogawa M.

Stat Med. 2006 Dec 15;25(23):3981-4003.

PMID:
16526008
16.

Nonparametric estimation for cumulative duration of adverse events.

Wang J, Quartey G.

Biom J. 2012 Jan;54(1):61-74. doi: 10.1002/bimj.201000256. Epub 2011 Dec 14.

PMID:
22170311
17.

Statistical methods to analyze adverse events data of randomized clinical trials.

Siddiqui O.

J Biopharm Stat. 2009 Sep;19(5):889-99. doi: 10.1080/10543400903105463.

PMID:
20183450
18.

A note on competing risks in survival data analysis.

Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD.

Br J Cancer. 2004 Oct 4;91(7):1229-35. Review.

19.
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk